In a statement, MSF called on ViiV Healthcare, to withdraw unacceptable conditions suddenly added to a long-negotiated purchase agreement for the preventative HIV drug cabotegravir long-acting (CAB-LA).
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/sBtOojU
Home »
Information and Updates: ET HealthWorld : ETHealthworld.com
,
Top Health News | Latest Healthcare Sector & Healthcare Industry news
» MSF says HIV drug deal on ice over pharma firm's price secrecy
https://ift.tt/hZdH7LT
No comments:
Post a Comment